↓ Skip to main content

Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies

Overview of attention for article published in BMC Cancer, October 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
1 X user
patent
1 patent
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
239 Dimensions

Readers on

mendeley
52 Mendeley